The global fight between Eli Lilly and Novo Nordisk for dominance in the red-hot weight-loss drug market is shifting to India, one of the fastest-growing pharmaceutical frontiers. As rising obesity and diabetes rates collide with expanding middle-class incomes, the country is becoming a pivotal battleground for the two drugmakers.On Thursday,…
In June, Russian exporters initiated the bidding process for their new wheat crop, setting a price of 14,500 rubles…
To achieve its ambitious climate targets, Britain needs to significantly lower its electricity prices, according to a recent progress…
European stock markets are looking at a cautiously positive start on Wednesday, with major indices edging higher as a…
Shares of Multi Commodity Exchange of India Ltd. (MCX) soared more than 6% on Wednesday to touch a record…
The much-awaited Axiom 4 launch took place in the early hours of Wednesday.At 2:31 AM EDT, Axiom‑4, the fourth…
Zohran Mamdani’s stunning political upset in the New York City’s Democratic primary for mayor not only renders a significant…
The National Stock Exchange of India (NSE), the nation’s largest exchange and the world’s most active derivatives exchange, has…